Sabzevari Helen

President and CEO

Sabzevari Helen has filed 5 SEC Form 4 filings (7 transaction rows) across 1 company, with disclosures dating back to 2026. 5 of those filings fall inside the rolling window. Most recent filing: Aug 25, 2026.

On the most recent filing, Sabzevari Helen is listed as President and CEO at PRECIGEN, INC. Inside the rolling window, Sabzevari Helen reported no open-market purchases and 2 open-market sales totaling $2.6M in PGEN. The largest disclosed transaction in the window is a sale of 346,836 PGEN shares on Jun 29, 2026, worth $2.0M.

Companies traded

Other insiders at PGEN

Insider Buying

$0

reported purchases (SEC code P)

Insider Selling

$2.6M

reported sales (SEC code S)

Companies

1

in the rolling window

Source
PGENSale$2.0MJul 1SEC ↗
PGENSale$520KJun 1SEC ↗
Showing 1–2 of 2
1 / 1

Frequently asked questions

How many SEC Form 4 filings has Sabzevari Helen made?

Sabzevari Helen has filed 5 SEC Form 4 filings (7 transaction rows) across 1 company since 2026.

Which companies does Sabzevari Helen trade?

Sabzevari Helen has filed SEC Form 4 disclosures for 1 company, including PGEN.

When was Sabzevari Helen's most recent SEC Form 4 filing?

Sabzevari Helen's most recent SEC Form 4 filing on Tracefour is dated Aug 25, 2026.

What is Sabzevari Helen's job title?

On the most recent SEC Form 4 filings tracked by Tracefour, Sabzevari Helen is listed as President and CEO.

What is Sabzevari Helen's total buy and sell value in the current window?

Inside the rolling retention window, Sabzevari Helen bought $0 and sold $2.6M based on SEC Form 4 filings.

What was Sabzevari Helen's largest disclosed transaction?

The largest disclosed transaction in the current window is a sale of 346,836 PGEN shares on 2026-06-29, worth $2.0M, per SEC Form 4 filings.